Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Acquisitions (2018)

Rocket Pharmaceuticals' Acquisitions history spans 1 years, with the latest figure at $76.3 million for Q1 2018.

  • For Q1 2018, Acquisitions changed N/A year-over-year to $76.3 million; the TTM value through Dec 2018 reached $76.3 million, changed N/A, while the annual FY2022 figure was $42.7 million, N/A changed from the prior year.
  • Acquisitions for Q1 2018 was $76.3 million at Rocket Pharmaceuticals.
  • Across five years, Acquisitions topped out at $76.3 million in Q1 2018 and bottomed at $76.3 million in Q1 2018.